🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06543602
Recruiting Observational

the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave

NCT06543602 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Started
2024-05-01
Last updated
2024-08-09

Condition(s) studied

Critically Ill Patients

Investigational drug(s) / intervention(s)

multi-model monitoring and alert

multi-model monitoring and alert: All agitated critically illed patients are monitored by manual and multi-model monitoring and alert system

Study summary

The goal of this observational study is to learn about the effectiveness of the multi-modal evaluation for agitation behavior in critically ill patients based on remote video-Ultra-sensitive detection wave.

The main question it aims to answer is: evaluate the effectiveness of multi-modal evaluation monitoring system for agitated critically ill patients Participants already taking multi-modal evaluation monitoring system as part of their regular medical care for agitated critically ill patients will compare their effectiveness for agitation for 3 years.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patients at risk of agitation in the ICU * Patients with RASS score -2 and above * ≦ 65 years old, ≧ 18 years old Exclusion Criteria: * The affected party refused to participate in this study * Missing/incomplete information * Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives * Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression * Patients with limb impairment and amputation * Spinal cord injury, limb movement/sensory limitations * Patients with pre-existing neurological/psychiatric diseases * Patients with malignant tumors * Patients with infectious diseases * Patients with terminal disease and dying disease * Abnormal behavior due to head injury or craniocerebral disease

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
the second affiliated hospital, Zhejiang University school of medicine Hangzhou Zhejiang Recruiting
SAHZU Hanzhou Zhejiang Active Not Recruiting

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06543602 on ClinicalTrials.gov ↗ ← All trials in China